Tekcis

Tekcis (Pertechnetate (99mTc) Sodium) is a radiopharmaceutical used in nuclear medicine imaging procedures. It emits gamma rays for diagnostic imaging of organs and tissues. Suitable for intravenous or ocular use under medical supervision. Short half-life ensures minimal radiation exposure.

Pertechnetate (99mTc) Sodium is primarily used in diagnostic imaging to visualize organs such as the thyroid, salivary glands, and brain. It helps identify abnormalities like tumors, cysts, or blockages in blood flow. The radiopharmaceutical is also used in ocular imaging to assess eye conditions. Commonly employed in nuclear medicine scans for functional evaluation.

As a radiopharmaceutical, Pertechnetate (99mTc) Sodium emits gamma radiation detectable by imaging equipment. The effects are temporary and localized to the area being examined. Patients may experience mild discomfort at the injection site. Imaging results are used to guide further medical evaluation or treatment.

Pertechnetate (99mTc) Sodium should only be handled and administered by trained healthcare professionals. Pregnant or breastfeeding individuals should avoid exposure due to radiation risks. Patients with known allergies to technetium compounds should inform their provider. Proper hydration is recommended post-procedure to aid in radiotracer clearance.

No significant drug interactions are reported with Pertechnetate (99mTc) Sodium. However, medications affecting thyroid function may influence imaging results. Patients should disclose all current medications to their healthcare provider. Alcohol and certain foods may interfere with imaging accuracy and should be avoided as directed.